Estrogen Receptors and Human Disease: an Update

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 2012 Jun 1

PMID 22648069

Citations 108

Authors

Katherine A Burns

Kenneth S Korach

Affiliations

Soon will be listed here.

Abstract

A myriad of physiological processes in mammals are influenced by estrogens and the estrogen receptors (ERs), ERα and ERβ. As we reviewed previously, given the widespread role for estrogen in normal human physiology, it is not surprising that estrogen is implicated in the development or progression of a number of diseases. In this review, we are giving a 5-year update of the literature regarding the influence of estrogens on a number of human cancers (breast, ovarian, colorectal, prostate, and endometrial), endometriosis, fibroids, and cardiovascular disease. A large number of sophisticated experimental studies have provided insights into human disease, but for this review, the literature citations were limited to articles published after our previous review (Deroo and Korach in J Clin Invest 116(3):561-570, 2006) and will focus in most cases on human data and clinical trials. We will describe the influence in which estrogen's action, through one of or both of the ERs, mediates the aforementioned human disease states.

Citing Articles

Deep learning and genome-wide association meta-analyses of bone marrow adiposity in the UK Biobank.

Xu W, Mesa-Eguiagaray I, Morris D, Wang C, Gray C, Sjostrom S Nat Commun. 2025; 16(1):99.

PMID: 39747859 PMC: 11697225. DOI: 10.1038/s41467-024-55422-4.

Perspective: the evolution of hormones and person perception-a quantitative genetic framework.

Gurguis C, Kimm T, Pigott T Front Psychol. 2024; 15:1395974.

PMID: 38952835 PMC: 11215136. DOI: 10.3389/fpsyg.2024.1395974.

N-methyladenosine demethyltransferase FTO mediated mA modification of estrogen receptor alpha in non-small cell lung cancer tumorigenesis.

Xu X, Qiu S, Zeng B, Huang Y, Wang X, Li F Oncogene. 2024; 43(17):1288-1302.

PMID: 38443681 DOI: 10.1038/s41388-024-02992-8.

A mini-review of the evidence for cerebrovascular changes following gender-affirming hormone replacement therapy and a call for increased focus on cerebrovascular transgender health.

Wright M, Murphy K Front Hum Neurosci. 2023; 17:1303871.

PMID: 38077183 PMC: 10702528. DOI: 10.3389/fnhum.2023.1303871.

ER-α36 is involved in calycosin inhibition of IL-6 production in macrophages.

Wu G, Qi G, Liu Y, Gan J, Xie C, Wu Q J Cell Mol Med. 2023; 28(1):e18037.

PMID: 37974543 PMC: 10805506. DOI: 10.1111/jcmm.18037.

References

Yan M, Rayoo M, Takano E, Fox S . Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers. Breast Cancer Res Treat. 2010; 126(2):395-405. DOI: 10.1007/s10549-010-0941-9. View

Novelli F, Milella M, Melucci E, Di Benedetto A, Sperduti I, Perrone-Donnorso R . A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. Breast Cancer Res. 2008; 10(5):R74. PMC: 2614505. DOI: 10.1186/bcr2139. View

Bolego C, Rossoni G, Fadini G, Vegeto E, Pinna C, Albiero M . Selective estrogen receptor-alpha agonist provides widespread heart and vascular protection with enhanced endothelial progenitor cell mobilization in the absence of uterotrophic action. FASEB J. 2010; 24(7):2262-72. DOI: 10.1096/fj.09-139220. View

Saleiro D, Murillo G, Lubahn D, Kopelovich L, Korach K, Mehta R . Enhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice. Cancer Prev Res (Phila). 2010; 3(9):1198-204. PMC: 2933324. DOI: 10.1158/1940-6207.CAPR-10-0044. View

Peddada S, Laughlin S, Miner K, Guyon J, Haneke K, Vahdat H . Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008; 105(50):19887-92. PMC: 2604959. DOI: 10.1073/pnas.0808188105. View

Lurie G, Wilkens L, Thompson P, Shvetsov Y, Matsuno R, Carney M . Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One. 2011; 6(6):e20703. PMC: 3108970. DOI: 10.1371/journal.pone.0020703. View

Chen Y, Kraft P, Bretsky P, Ketkar S, Hunter D, Albanes D . Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2007; 16(10):1973-81. DOI: 10.1158/1055-9965.EPI-07-0431. View

Lebeau A, Grob T, Holst F, Seyedi-Fazlollahi N, Moch H, Terracciano L . Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions. J Pathol. 2008; 216(2):151-7. DOI: 10.1002/path.2405. View

Tsezou A, Tzetis M, Gennatas C, Giannatou E, Pampanos A, Malamis G . Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer. Breast. 2007; 17(2):159-66. DOI: 10.1016/j.breast.2007.08.007. View

10.

Zhu J, Hua K, Sun H, Yu Y, Jin H, Feng Y . Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells. Oncol Rep. 2011; 26(6):1497-503. DOI: 10.3892/or.2011.1430. View

11.

van de Water W, Markopoulos C, van de Velde C, Seynaeve C, Hasenburg A, Rea D . Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA. 2012; 307(6):590-7. DOI: 10.1001/jama.2012.84. View

12.

Chen Y, Jin X, Zeng Z, Liu W, Wang B, Wang H . Estrogen-replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing SDF-1 and estrogen receptor expression. Microvasc Res. 2008; 77(2):71-7. DOI: 10.1016/j.mvr.2008.10.003. View

13.

Bukulmez O, Hardy D, Carr B, Word R, Mendelson C . Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology. 2007; 149(3):1190-204. PMC: 2275353. DOI: 10.1210/en.2007-0665. View

14.

Chen J, Russo P, Cooke C, Russo I, Russo J . ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim Biophys Acta. 2007; 1773(12):1732-46. DOI: 10.1016/j.bbamcr.2007.05.008. View

15.

Lagiou P, Georgila C, Samoli E, Lagiou A, Zourna P, Minaki P . Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk. Int J Cancer. 2008; 124(2):440-2. PMC: 2605180. DOI: 10.1002/ijc.23899. View

16.

Brodowska A, Laszczynska M, Starczewski A, Karakiewicz B, Brodowski J . The localization of estrogen receptor alpha and its function in the ovaries of postmenopausal women. Folia Histochem Cytobiol. 2008; 45(4):325-30. View

17.

Karita M, Yamashita Y, Hayashi A, Yoshida Y, Hayashi M, Yamamoto H . Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulosa cells?. Fertil Steril. 2011; 95(3):889-94. DOI: 10.1016/j.fertnstert.2010.12.026. View

18.

Zulli K, Bianco B, Mafra F, Teles J, Christofolini D, Barbosa C . Polymorphism of the estrogen receptor β gene is related to infertility and infertility-associated endometriosis. Arq Bras Endocrinol Metabol. 2010; 54(6):567-71. DOI: 10.1590/s0004-27302010000600010. View

19.

Mandusic V, Nikolic-Vukosavljevic D, Tanic N, Kanjer K, Neskovic-Konstantinovic Z, Celeketic D . Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer. J Cancer Res Clin Oncol. 2007; 133(8):571-9. DOI: 10.1007/s00432-007-0209-x. View

20.

Hewitt S, OBrien J, Jameson J, Kissling G, Korach K . Selective disruption of ER{alpha} DNA-binding activity alters uterine responsiveness to estradiol. Mol Endocrinol. 2009; 23(12):2111-6. PMC: 2796155. DOI: 10.1210/me.2009-0356. View